BGP-15 co-treatment protects against oxaliplatin-induced neuronal loss and alleviates gastrointestinal dysfunction

Full text for this resource is not available from the Research Repository.

McQuade, Rachel, Stojanovska, Vanesa, Sorensen, JC, Bornstein, JC, Petersen, Aaron ORCID: 0000-0003-1508-748X, Rybalka, Emma ORCID: 0000-0002-4854-0036 and Nurgali, Kulmira ORCID: 0000-0002-2597-6929 (2016) BGP-15 co-treatment protects against oxaliplatin-induced neuronal loss and alleviates gastrointestinal dysfunction. Neurogastroenterology and Motility, 28 (S1). 52 - 53. ISSN 1365-2982

Abstract

Abstract of the Oral Presentation at the 2nd Federation of Neurogastroenterology and Motility Meeting - FNM 2016 Joint International Meeting, August 25–28, 2016 Hyatt Regency San Francisco, San Francisco, California, USA

Item type Article
URI https://vuir.vu.edu.au/id/eprint/33276
Official URL http://onlinelibrary.wiley.com/doi/10.1111/nmo.128...
Subjects Historical > FOR Classification > 1103 Clinical Sciences
Historical > FOR Classification > 1115 Pharmacology and Pharmaceutical Sciences
Historical > Faculty/School/Research Centre/Department > Institute of Sport, Exercise and Active Living (ISEAL)
Current > Division/Research > College of Health and Biomedicine
Keywords GI function; myenteric neurons; BGP15; OXL therapy
Download/View statistics View download statistics for this item

Search Google Scholar

Repository staff login